ZA99454B - Novel dosage form. - Google Patents

Novel dosage form.

Info

Publication number
ZA99454B
ZA99454B ZA9900454A ZA99454A ZA99454B ZA 99454 B ZA99454 B ZA 99454B ZA 9900454 A ZA9900454 A ZA 9900454A ZA 99454 A ZA99454 A ZA 99454A ZA 99454 B ZA99454 B ZA 99454B
Authority
ZA
South Africa
Prior art keywords
dosage form
novel dosage
novel
dosage
Prior art date
Application number
ZA9900454A
Inventor
Peter James Watts
Lisbeth Illum
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of ZA99454B publication Critical patent/ZA99454B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
ZA9900454A 1998-01-22 1999-01-21 Novel dosage form. ZA99454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form

Publications (1)

Publication Number Publication Date
ZA99454B true ZA99454B (en) 2000-10-23

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900454A ZA99454B (en) 1998-01-22 1999-01-21 Novel dosage form.

Country Status (9)

Country Link
EP (1) EP1059918A1 (en)
JP (1) JP2002501016A (en)
AR (1) AR014467A1 (en)
AU (1) AU2176099A (en)
CA (1) CA2318257A1 (en)
GB (1) GB9801363D0 (en)
NO (1) NO20003640L (en)
WO (1) WO1999037290A1 (en)
ZA (1) ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
SI1889198T1 (en) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
CN101496042A (en) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 Patient customized therapeutic regimens
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
ES2930588T3 (en) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Ingestible Event Marker Systems
KR101528748B1 (en) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 In-body power source having high surface area electrode
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
DK2192946T3 (en) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
SG190590A1 (en) 2007-11-27 2013-06-28 Proteus Digital Health Inc Transbody communication systems employing communication channels
ES2840773T3 (en) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Multimode Communication Ingestible Event Markers and Systems
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
WO2010132331A2 (en) 2009-05-12 2010-11-18 Proteus Biomedical, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
AU2011237612B2 (en) * 2010-04-07 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
MX340001B (en) 2011-07-21 2016-06-20 Proteus Digital Health Inc Mobile communication device, system, and method.
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
RU2015105699A (en) 2012-07-23 2016-09-10 Протеус Диджитал Хелс, Инк. METHODS FOR PRODUCING INGESTED EVENT MARKERS CONTAINING AN INGESTED COMPONENT
JP5869736B2 (en) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド Apparatus, system, and method for adaptively optimizing power dissipation and broadcast power in a power supply for a communication device
TWI659994B (en) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 Highly-swellable polymeric films and compositions comprising the same
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド Metal detector device, system and method
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
BR112019000861B1 (en) 2016-07-22 2020-10-27 Proteus Digital Health, Inc electronic device
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (en) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (en) * 1987-07-23 1991-10-04 Synthelabo PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

Also Published As

Publication number Publication date
EP1059918A1 (en) 2000-12-20
NO20003640L (en) 2000-09-12
AR014467A1 (en) 2001-02-28
NO20003640D0 (en) 2000-07-14
AU2176099A (en) 1999-08-09
WO1999037290A1 (en) 1999-07-29
CA2318257A1 (en) 1999-07-29
GB9801363D0 (en) 1998-03-18
JP2002501016A (en) 2002-01-15

Similar Documents

Publication Publication Date Title
ZA99454B (en) Novel dosage form.
EG24814A (en) Novel compounds.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
MXPA01013362A (en) ANTI-alphav.
HK1042653A1 (en) External preparation.
ZA200004956B (en) Vaccine composition.
MXPA02001088A (en) 2 pyrazolin 5 ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA993345B (en) Nefazodone dosage form.
HK1038884A1 (en) Medicinal compositions.
ZA200202537B (en) Pour-on-formulations.
ZA991272B (en) Novel thiobenzamides.
HK1051199A1 (en) New phenylpiperazines.
ZA996133B (en) Substituted benzamides.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
ZA200108968B (en) New compounds.
ZA200005510B (en) Pharmaceutical composition.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
HK1036280A1 (en) Antivirals.
HK1044117A1 (en) Pharmaceutical composition.
MXPA02000261A (en) Novel aminoindanes.
ZA99890B (en) Pharmaceutical compositions.